Hyperthyroidism Management
Hyperthyroidism management identifies the cause and selects the most appropriate treatment — medication, radioactive iodine, or surgery — with ongoing monitoring.
This service provides specialist care for hyperthyroid patients.
Last medically reviewed: 1 November 2025
Cause identification
Determining whether hyperthyroidism is due to Graves’ disease, toxic nodules, thyroiditis, or other causes — essential because treatment differs. TRAb testing, ultrasound, and RAIU help distinguish.
Treatment selection
Antithyroid drugs for Graves’ (12–18 month course), radioactive iodine for relapse or nodular disease, surgery for large goitres or eye disease. Beta-blockers control symptoms meanwhile.
The choice is individualised — age, cause, severity, eye involvement, and patient preference all matter.
Monitoring
Thyroid function is monitored closely during treatment — every 4–6 weeks initially. After definitive treatment, lifelong monitoring continues because hypothyroidism is the expected outcome.
Frequently asked questions
Which treatment is best?
It depends on cause and patient factors — antithyroid drugs suit those wanting to avoid permanent effects; RAI is convenient; surgery suits large goitres or eye disease. There is no single best option.
Will I become hypothyroid?
Likely after RAI or surgery — this is expected and managed with levothyroxine. Antithyroid drugs may allow remission without hypothyroidism.
How serious is untreated hyperthyroidism?
It can cause atrial fibrillation, osteoporosis, heart failure, and rarely thyroid storm — a medical emergency. Prompt treatment is important.
References & further reading
This page is based on established medical knowledge and guidelines from authoritative sources. Always consult a qualified clinician for personal medical advice.
Ready to discuss your thyroid health?
Book a specialist consultation — in person or by teleconsultation.